Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials

This publication has 17 references indexed in Scilit:

• A survey of american women regarding the use of oral contraceptives and weight gain
  International Journal of Gynecology & Obstetrics, 2000
• Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparations
  Contraception, 1999
• Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®)
  American Journal of Obstetrics and Gynecology, 1999
• Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence
  Contraception, 1999
• International clinical experience with a new low-dose, Monophasic oral contraceptive containing levonorgestrel 100 μg and ethinyl estradiol 20 μg
  Clinical Therapeutics, 1999
• Weight change with oral contraceptive use and during the menstrual cycle
  Contraception, 1998
• A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles
  Contraception, 1997
• Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women
  Fertility and Sterility, 1995
• Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patients
  American Journal of Obstetrics and Gynecology, 1992
• A comparative analysis of three different dose combinations of oral contraceptives
  Contraception, 1989